BioSyent Releases Results for Fourth Quarter and Full Year 2018
March 20, 2019 08:00 ET
|
BioSyent Inc.
TORONTO, March 20, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today a summary of its financial results for the three and twelve months ended December 31, 2018. Key...
BioSyent Schedules Q4 2018 Earnings Release for March 20, 2019
March 15, 2019 12:35 ET
|
BioSyent Inc.
TORONTO, March 15, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and twelve months ended December 31, 2018...
BioSyent Announces Normal Course Issuer Bid
December 04, 2018 08:00 ET
|
BioSyent Inc.
TORONTO, Dec. 04, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that the TSX Venture Exchange (“TSX-V”) has accepted the Company’s Notice...
BioSyent Releases Results for Third Quarter and First Nine Months of 2018
November 21, 2018 08:00 ET
|
BioSyent Inc.
TORONTO, Nov. 21, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today a summary of its financial results for the three and nine months ended September 30, 2018. Key...
BioSyent Schedules Q3 2018 Earnings Release for November 21, 2018
November 08, 2018 09:22 ET
|
BioSyent Inc.
TORONTO, Nov. 08, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and nine months ended September 30, 2018...
BioSyent Named to the Growth 500 Ranking of Canada's Fastest-Growing Companies for Sixth Consecutive Year
September 13, 2018 09:00 ET
|
BioSyent Inc.
TORONTO, Sept. 13, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it has been named to the annual Growth 500 ranking of Canada’s Fastest-Growing...
BioSyent Announces Changes to Executive Management
September 10, 2018 17:28 ET
|
BioSyent Inc.
TORONTO, Sept. 10, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) today announced changes to its Executive Management team: Effective on September 10, 2018, Mr....
BioSyent to Present at Upcoming Investor Conference
August 24, 2018 12:00 ET
|
BioSyent Inc.
TORONTO, Aug. 24, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”) (TSX Venture: RX) is pleased to announce that it will be presenting at the Midwest IDEAS Investor Conference at...
BioSyent Releases Q2 and H1 2018 Results
August 22, 2018 08:00 ET
|
BioSyent Inc.
TORONTO, Aug. 22, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today a summary of its financial results for the three and six months ended June 30, 2018. Key...
BioSyent Schedules Q2 2018 Earnings Release for August 22, 2018
August 10, 2018 08:00 ET
|
BioSyent Inc.
TORONTO, Aug. 10, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and six months ended June 30, 2018 on...